J. Jeffrey Goater
2020
In 2020, J. Jeffrey Goater earned a total compensation of $2.3M as Director, former Chief Executive Officer, President and Senior Advisor at Surface Oncology, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $443,025 |
|---|---|
| Option Awards | $516,313 |
| Salary | $537,000 |
| Stock Awards | $817,260 |
| Other | $10,113 |
| Total | $2,323,711 |
Goater received $817.3K in stock awards, accounting for 35% of the total pay in 2020.
Goater also received $443K in non-equity incentive plan, $516.3K in option awards, $537K in salary and $10.1K in other compensation.
Rankings
In 2020, J. Jeffrey Goater's compensation ranked 4,878th out of 13,090 executives tracked by ExecPay. In other words, Goater earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,878 out of 13,090 | 63rd |
Division Manufacturing | 1,984 out of 5,621 | 65th |
Major group Chemicals And Allied Products | 785 out of 2,254 | 65th |
Industry group Drugs | 677 out of 1,954 | 65th |
Industry Biological Products, Except Diagnostic Substances | 160 out of 411 | 61st |
Source: SEC filing on April 26, 2022.
Goater's colleagues
We found three more compensation records of executives who worked with J. Jeffrey Goater at Surface Oncology in 2020.